# Arkema account plan

> Arkema is a French Specialty Materials group (adhesives, advanced polymers, coatings) in 55 countries with 20,700 employees; 2025 sales €9,068 million.

## At a glance

Arkema is a French Specialty Materials group whose businesses create and strengthen materials, bond and assemble them, and protect and modify them, serving general industry, consumer goods and electronics, building, transportation and energy, and health. It operates in 55 countries with 154 sites and 17 R&D centers; 2025 sales split North America 34%, Europe 33%, Asia 28% and rest of the world 5%. In 2025 sales were €9,068 million (-5.0%), EBITDA fell 18.3% to €1,251 million (13.8% margin) and net income (Group share) was €63 million, with 20,700 employees. Thierry Le Hénaff is Chairman and CEO; Bpifrance Investissement and Fonds Stratégique de Participations sit on the Board.

## Business units

- **Advanced Materials** (38% of 2025 sales (€3,441m)): High Performance Polymers (specialty polyamides Rilsan® and Pebax®, Kynar® PVDF, PIAM polyimide films, Kepstan® PEKK, fluorospecialties) and Performance Additives (thiochemicals, specialty surfactants, peroxides, molecular sieves). 2025 EBITDA was €616 million (17.9% margin) and the normalized target is 23%; H1 2026 margin fell to 18.0% as Performance Additives were hit by the Middle East crisis.
- **Adhesive Solutions (Bostik)** (30% of 2025 sales (€2,737m)): World number three in adhesives and sealants, with Industrial Assembly and Construction & Consumer lines, 76 production units in 43 countries. 2025 EBITDA was €365 million (13.3% margin) against a 17% target; H1 2026 was helped by aerospace, consumer electronics and industrial assembly while construction showed no recovery. Led by Laurent Peyronneau.
- **Coating Solutions** (24% of 2025 sales (€2,176m)): Coating resins and acrylic monomers, Sartomer photocure resins and Coatex rheology additives for paints, industrial coatings, electronics and 3D printing. 2025 sales fell 11.4% in the acrylics low cycle, but H1 2026 EBITDA rose 26.6% to €129.0 million (15.9% margin) after a refocus on higher value-added applications. Led by Richard Jenkins.
- **Primary Materials** (15% of H1 2026 sales (€695.5 million)): Created on 1 January 2026 to group the cyclical businesses: global acrylic monomers, legacy refrigerants expected to phase out around 2030, and hydrogen peroxide. H1 2026 EBITDA was €90.5 million (13.0% margin) as the Middle East conflict lifted acrylic prices.
- **Intermediates (discontinued from 2026)** (8% of 2025 sales (€681m)): Fluorogases (Forane® refrigerants) and Asia Acrylics until end-2025; 2025 EBITDA was €162 million. Its businesses were redistributed into Primary Materials and Advanced Materials in the 2026 resegmentation.

## Strategic priorities

- **2028 ambition**: Under normalized conditions, about €12bn of sales and about 18% EBITDA margin by 2028, with net debt and hybrids below 2x EBITDA and ROCE of about 10% (5.4% in 2025).
- **Five key high-growth markets**: Batteries and e-mobility, advanced electronics, sustainable goods, efficient buildings and health grew sales 16% in 2025, and more than 50% of R&D spend goes to them.
- **Specialty Materials focus**: The new segmentation separates Specialty Materials (about 85% of sales) from Primary Materials; the CEO says there is "never any taboo" on disposals.
- **Cost savings and headcount**: About €90 million of savings in 2025, the €250 million cumulative 2028 target expected two years early, and headcount down about 3% a year over the next three years.
- **Bolt-on acquisitions**: Targeted in high-growth markets and fragmented adhesives, aiming for EV/EBITDA of about 7-8x four to five years after a deal.
- **Decarbonization**: 2030 targets include 60% of sales from ImpACT+ solutions (57% in 2025) and Scope 3 emissions -67% versus 2019.

## Latest results

In H1 2026, the first half reported under the new segmentation, sales were €4,610 million (-3.5%, stable at constant currencies) and EBITDA €674 million (-2.7%) at a 14.6% margin; excluding a currency effect of about €30 million, EBITDA grew about 1%. Specialty Materials delivered €630 million of EBITDA (16.2% margin), led by Coating Solutions, while Advanced Materials' margin fell to 18.0%. Net income (Group share) was €92.9 million. Net debt and hybrid bonds rose to €3,605 million (2.9x LTM EBITDA) after the €3.60 dividend. Arkema confirmed its guidance of FY'26 EBITDA slightly higher than last year at constant currencies, with about €50 million of additional EBITDA from projects.

## Investments and deals

- **PVDF expansions**: Calvert City +15% started up on 23 June 2026 for energy storage, semiconductors and data centers; a further +20% at Changshu was announced in March 2026 for 2028.
- **Asian polymer capacity**: Amino-11/PA11 in Singapore (€450 million, +50% amino-11 capacity) and Rilsan® Clear in Singapore, started in January 2026 and tripling capacity.
- **US projects**: A 15 kt/year Forane® 1233zd unit at Calvert City and a DMDS expansion at Beaumont (+35%).
- **Carling acrylics site**: A €130 million investment in new purification technology at the Carling acrylic monomer site in France, cutting CO2 by 20%.
- **Portfolio moves**: Part of the impact modifiers and processing aids business was sold to Praana on 1 July 2026; Dow's laminating adhesives were acquired at end-2024. Capex is limited to about €600 million in 2026.

## Challenges and risks

- **Weak demand in Europe and the US**: Tariffs weighed on demand, construction shows no recovery and customers kept inventories tight; the CEO called 2025 one of the most difficult years in 20 years for the industry.
- **Middle East conflict**: Since late February 2026 raw material increases have run from a few percent to 100%, energy and logistics costs rose, and Performance Additives lost Middle East sales and faced higher sulfur costs.
- **Acrylics cycle and legacy refrigerants**: The low cycle in upstream acrylics and the decline of old-generation refrigerants explained most of the 2025 EBITDA drop.
- **Currency and Chinese overcapacity**: FX cost about €40 million of EBITDA in 2025 and about €30 million in H1 2026; Chinese overcapacity is a named competitive risk.
- **Leverage**: Net debt and hybrid bonds reached 2.9x LTM EBITDA at mid-2026, above the below-2x target.

## What leadership says

> "probably one of the most difficult our industry has faced in the last 20 years" — Thierry Le Hénaff, Chairman and CEO, Full-year 2025 results call, 26 February 2026

> "this crisis will have a positive and negative impacts. But all in all, for Arkema, it should be around neutral." — Thierry Le Hénaff, Chairman and CEO, On the Middle East conflict, Q1 2026 results call, 6 May 2026

> "is an engine of growth and profitability for the company" — Thierry Le Hénaff, Chairman and CEO, On PVDF, Q1 2026 results call, 6 May 2026

> "we made the choice not to reduce our innovation efforts" — Thierry Le Hénaff, Chairman and CEO, 2025 Universal Registration Document, March 2026


## Where a supplier can help

- **Battery and electronics materials partnerships**: Growth in batteries, electronics and 3D printing (about 15% in H1 2026) and the PVDF expansions suit partners in cell manufacturing, semiconductors and data-center supply chains.
- **Procurement and raw-material risk**: Raw-material swings from a few percent to 100% after the Middle East conflict open doors for sourcing, commodity-risk and pricing-analytics providers.
- **Operational efficiency and digitalization**: The cost-savings programme, a 3% annual headcount decline and the manufacturing excellence lever point to automation, maintenance and digital plant tools.
- **Decarbonization at sites**: Projects such as Carling, biomethane supply and the 2030 Scope 3 target create demand for low-carbon energy, process technology and life-cycle assessment services.
- **Commercial excellence**: The One Arkema key account model, the My.Arkema portal and the data center platform fit CRM, customer-portal and sales-enablement vendors.

_Tamtam's reading of the priorities and challenges above, not the company's own words._

## Key documents

### [2025 Universal Registration Document (including the annual financial report)](https://www.arkema.com/files/live/sites/shared_arkema/files/downloads/investorrelations/en/finance/ARKEMA_URD_2025_UK_MEL.pdf)

Annual report · 2026-03-26

- Arkema is a French Specialty Materials group: 2025 sales of €9,068 million (-5.0%), 20,700 employees, operations in 55 countries, €284 million of R&D (3.1% of sales) and more than 1,800 researchers in 17 R&D centers.
- 2025 was hard: EBITDA fell 18.3% to €1,251 million (13.8% margin), REBIT was €564 million and net income (Group share) €63 million. The CEO cites tariffs that weighed on demand in Europe and North America, the low cycle in upstream acrylics and the decline of old-generation refrigerants.
- Cash held up. Recurring cash flow was €464 million (against €300 million revised guidance), capex fell to €636 million, net debt and hybrid bonds came to €3,170 million (2.5x EBITDA), and the dividend stays at €3.60.
- 2025 sales by segment: Advanced Materials 38% (€3,441m), Adhesive Solutions (Bostik) 30% (€2,737m), Coating Solutions 24% (€2,176m) and Intermediates 8% (€681m). By region: North America 34%, Europe 33%, Asia 28% and rest of the world 5%.
- From 2026 a new Primary Materials segment groups the more cyclical businesses: global acrylic monomers, legacy refrigerants, and hydrogen peroxide with some derivatives. Intermediates is discontinued, and Specialty Materials make up about 85% of 2025 sales.
- The CMD 2023 ambition under normalized conditions is about €12bn of sales and about 18% EBITDA margin by 2028. Five key high-growth markets (batteries/e-mobility, advanced electronics, sustainable goods, efficient buildings, health) grew sales 16% in 2025.
- Growth projects added about €60 million of EBITDA in 2025, with about €50 million more expected in 2026. Projects include PVDF expansions (Calvert City +15%, Changshu +20% by 2028), Rilsan® Clear in Singapore, DMDS in Beaumont and Forane® 1233zd in Calvert City.
- Cost savings reached about €90 million in 2025. Headcount is expected to decline by about 3% a year over the next three years, and capex is set at about €600 million in 2026.
- 2026 guidance: slight EBITDA growth at constant currencies. Main risks named: the Middle East conflict (higher oil, gas and raw material costs), tariffs, FX (US dollar, yuan, won) and Chinese overcapacity.

### [Half-year financial report 2026](https://www.arkema.com/files/live/sites/shared_arkema/files/downloads/investorrelations/en/finance/arkema-financial-report-half-year-2026.pdf)

Interim report · 2026-07-30

- H1 2026 sales were €4,610 million (-3.5%), stable at constant currencies. Volumes fell 1.0%, price had a +1.0% effect and currency a -3.2% effect.
- EBITDA was €674 million (-2.7%), with a 14.6% margin (14.5% in H1'25). The currency effect was about €30 million; excluding it, EBITDA grew about 1%.
- First report under the new segmentation. Specialty Materials made up 85% of sales and €630 million of EBITDA (16.2% margin). Primary Materials made up 15% of sales and €91 million of EBITDA (13.0% margin, against 10.1%).
- Coating Solutions stood out, with EBITDA up 26.6% to €129 million (15.9% margin). Sartomer volumes rose in all three regions.
- Advanced Materials EBITDA fell to €302 million (18.0% margin, from 20.6%). Performance Additives were hit by the Middle East crisis, weaker refining and fertilizer demand, and higher sulfur costs.
- Adhesive Solutions held steady: EBITDA of €200 million at a 14.2% margin, helped by aerospace, consumer electronics and industrial assembly. Construction showed no recovery.
- Batteries, electronics and 3D printing grew about 15%. Major projects added about €25 million of EBITDA. The Rilsan® Clear (Singapore) and Calvert City PVDF (+15%) units started up.
- Net debt and hybrid bonds were €3,605 million (2.9x LTM EBITDA) after paying the €3.60 dividend. Capex was €191 million, against €600 million guided for the year.
- Laurent Tellier became COO on 1 July 2026, replacing Marc Schuller. The plastic additives sale to Praana closed on 1 July. Guidance is confirmed: FY'26 EBITDA slightly higher at constant currencies.

### [Full-year 2025 results conference call transcript](https://www.roic.ai/quote/ARKAF/transcripts/2025-year/4-quarter)

Executive talk · Thierry Le Hénaff, Chairman and Chief Executive Officer (with Marie-José Donsion, Chief Financial Officer) · 2026-02-26

- In the FY2025 results call (26 February 2026), CEO Thierry Le Hénaff called 2025 "probably one of the most difficult our industry has faced in the last 20 years". EBITDA was EUR 1.25 billion (13.8% margin).
- Cash beat guidance: recurring cash flow was EUR 464 million against EUR 300 million revised guidance. Cost savings of about EUR 90 million nearly doubled the initial annual target, and the EUR 250 million cumulative savings target for 2028 should be reached two years early.
- Headcount fell more than 2% in 2025, and a further reduction of around 3% a year is expected over the next 3 years.
- The new Primary Materials segment (acrylics, old-generation refrigerants) aims to show that Specialty Materials, about 85% of the portfolio, saw EBITDA fall only about 5% in trough conditions. Acrylics "remains a backbone" and there is "never any taboo" on disposals.
- Key markets (batteries, sports, 3D printing, healthcare, low-GWP fluorospecialties) grew sales 16%. Projects added about EUR 60 million of EBITDA in 2025, with about EUR 50 million expected in 2026.
- Capex will be reduced to EUR 600 million in 2026. PIAM is benefiting from foldable and ultra-slim smartphones.
- Q4 weakness in High Performance Polymers was attributed to customer destocking in Europe and the US and to geographic mix, not to competition.
- CFO Marie-José Donsion: net debt and hybrid bonds were EUR 3.2 billion (2.5x EBITDA), working capital 12.5% of sales, and the EUR 300 million hybrid was redeemed in January 2026.
- 2026 guidance: slight EBITDA growth at constant FX, with a Q1 currency hit of about EUR 25 million and halves more balanced than in 2025.

### [First-quarter 2026 results conference call transcript](https://www.roic.ai/quote/ARKAF/transcripts/2026-year/1-quarter)

Executive talk · Thierry Le Hénaff, Chairman and Chief Executive Officer (with Marie-José Donsion, Chief Financial Officer) · 2026-05-06

- In the Q1 2026 results call (6 May 2026), Thierry Le Hénaff said demand stayed soft in January and February 2026 before improving in March. Europe and the US were subdued and Asia had solid momentum.
- Q1 EBITDA was EUR 283 million, up 14% on Q4 2025, with a currency hit of about EUR 20 million. Specialty Materials volumes rose 1.5%, and volumes in batteries, sport, 3D printing and healthcare rose 15%.
- On the Middle East war, raw material increases run "from a few percent to 100%". Prices are being raised selectively so as to fully offset them by quarter-end, and so far Arkema has had no supply disruption.
- Overall he expects the crisis "should be around neutral" for Arkema: acrylics benefit, Performance Additives (Middle East customers, sulfur costs) lose.
- PIAM's Q1 EBITDA rose more than 30% year-on-year in local currency at a 35% margin, driven by foldable and ultra-thin smartphones.
- He defended further PVDF investment (US +15% mid-year, China +20% for 2028): PVDF is "an engine of growth and profitability" with a high-end focus.
- Advanced Materials' mid-term margin target was confirmed "well above the 20%". Current dilution is mechanical, because Asian unit margins are lower.
- Net debt and hybrids were EUR 3.3 billion (2.8x LTM EBITDA). Capex is on track for EUR 600 million, and the target of slight EBITDA growth at constant FX in 2026 is confirmed.
- On Arkema's 20 years since listing: EUR 1 invested in May 2006 "has become EUR 3.6 today, including dividends".

## Questions about Arkema

### What does Arkema do?

Arkema makes specialty materials: Bostik adhesives, advanced polymers such as PVDF and polyamides, performance additives and coating resins, plus acrylics and refrigerants in its Primary Materials segment, for industries from batteries to construction.

### What is Arkema's revenue?

2025 sales were €9,068 million, down 5.0%, with EBITDA of €1,251 million. H1 2026 sales were €4,610 million.

### How many employees does Arkema have?

20,700 employees in 2025, with headcount expected to decline by about 3% a year over the next three years.

### What is Arkema's strategy?

To grow Specialty Materials in five high-growth markets through innovation, major capex ramp-ups and bolt-on acquisitions, targeting about €12bn of sales and about 18% EBITDA margin by 2028 under normalized conditions.

### Who leads Arkema?

Thierry Le Hénaff is Chairman and CEO, Marie-José Donsion is CFO, and Laurent Tellier became COO on 1 July 2026.

_Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)_
